CRT-102 Everolimus-Eluting Bioresorbable Vascular Scaffold Use in Acute Coronary Syndromes: Initial Clinical Experience from South Western Canada  by Sultan, Ayyaz et al.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 8 , N O . 2 , S U P P L S , 2 0 1 5 S9Plaque Rupture
(n[90)Plaque Erosion
(n[43) P valueLesion length (mm) 18.497.53 14.895.55 0.003
Distal reference lumen area (mm2) 7.543.2 7.172.82 0.53
Minimal lumen area (mm2) 3.21.69 4.23.05 0.018
Rupture vs erosion sitesEEM (mm2) 17.685.93 15.077.48 0.0359
lumen area (mm2) 6.082.85 7.023.29 0.11
Plaque area (mm2) 11.614.6 7.293.38 <0.0001
Plaque burden (%) 65.0812.15 50.516.63 <0.0001
%Fibrotic area 55.0313.65 71.73105.9 0.14C%Fibrofatty area 11.9811.76 15.2316.51 0.27O
R%Necrotic core area 24.7411.07 15.0612.47 <0.0001O
N%Dense calcium 8.248.96 6.3410.18 0.29A
RRemodeling Index 1.120.29 0.940.36 0.005YRemodeling 0.003Positive (%) 52(57.7) 14(32.5)Intermediate (%) 15(16.6) 4(9.3)Negative (%) 23(25.5) 25(58.1)CRT-102
Everolimus-Eluting Bioresorbable Vascular Scaffold Use in Acute Coronary
Syndromes: Initial Clinical Experience from South Western Canada
Ayyaz Sultan, Varinder Randhawa, Mistre Alemayehu, Shahar Lavi
London Health Sciences Centre, London, ON, Canada
BACKGROUND Contemporary studies have established encouraging clinical out-
comes for the everolimus-eluting bioresorbable vascular scaffold (BVS) ABSORB in
patients with stable coronary artery disease (CAD). There is limited data on its use in
patients presenting with acute coronary syndromes (ACS). We aimed to evaluate the
safety and efﬁcacy of BVS deployment in the setting of ACS at our tertiary cardiac
center in southwestern Ontario.
METHODS Retrospective chart review of all ACS with BVS use was undertaken since
June 2013. Data was analyzed for baseline demography and in-hospital and 30-day
mortality.
RESULTS 43 BVS were deployed in 30 patients. Mean age was 56.5+2.2 years; 30%
were female and 76.6% were less than 65 years old. Nearly 70% were hypertensive
and dyslipidemic, while one-third were diabetics and smokers. 50% of the patients
presented with STEMI, of which 86.7% received primary PCI. Mean total Syntax score
was 14.0+1.5 and 72.1% of lesions were ACC Type “B” lesions, with visible thrombus
present in one-third. Complete occlusion was seen in 18.6% of lesions at the outset.
62.8% were LAD lesions. All BVS were deployed in the ﬁrst attempt. 75% (33/43) of
BVS were post dilated. Final TIMI-3 ﬂow was evident in 42 (97.7%) patients, with no
case of worsening coronary ﬂow. 30% of all BVS were deployed across bifurcations
without any loss of coronary ﬂow in the side branches. There has been no reported
case of in-hospital or 30-day mortality, early stent thrombosis or repeat revasculari-
zation of the index artery.
CONCLUSIONS Our experience suggests that usage of BVS, in selected ’real-world’
patients with ACS, may be a safe and practical option with favorable short-term
outcomes. Long-term follow up data and further evaluation in larger randomized
controlled trials is needed.CRT-103
NSTEMI In Elderly Patients Treated With Early Revascularization: Long-term
Outcome.
Carolina D’ Anna,1 Federico Piscione,2 Giuseppe De Luca,3 Antonio Rapacciuolo,1
Giovanni Esposito,1 Plinio Cirillo,1 Rossella Luciano,1 Chiara De Biase,1
Bruno Trimarco,1 Gennaro Galasso1
1Federico II University, Naples, Italy; 2University of Salerno, Salerno, Italy; 3University
of Eastern Piedmont, Novara, Italy
BACKGROUND Elderly patients represent a larger proportion of patients with Non-ST
elevation acute coronary syndrome (NSTEACS), but their management is still unclear.
Recent studies report a mortality rate up to 50% in elderly NSTEACS patients
conservatively treated. The aim of this study is to analyze the long term outcome of
elderly NSTEACS patients undergoing percutaneous coronary intervention (PCI).
METHODS Study population consisted of 452 consecutive patients (75.43.8 years)
admitted, from January 2003 to January 2004, at our Institution with diagnosis of
NSTEACS and underwent PCI. All clinical, angiographic and follow- up data were
collected and entered into a dedicated database. The primary endpoint was the
combined of death, acute myocardial infarction, re- PCI or the need forrevascularization surgery. Follow-up was conducted at our outpatient clinic or by
phone interview.
RESULTS The mean follow-up was 8.7  1.6 years (range 0-10 years). According
with age, study population was divided into three groups: group 1 (n¼278; age 70-
75 years), group 2 (n¼130; age 75-80 years), group 3 (n¼44; age>80 years). Patients
of group 3 showed a signiﬁcantly higher incidence of diabetes (40.9%) compared
with other groups (21.6% and 33.8%, p¼0.003), while no other differences in
clinical and angiographic features were observed. The overall mortality at long-
term follow-up was 22.8%. The in hospital mortality was 1.9%. Subgroup analysis
showed a signiﬁcantly higher mortality in group 3 (43.2%) compared to the other
groups (21.4% group 1 and 19.2% group 2; p¼0.003). Multivariate analysis identi-
ﬁed age (c¼5.2; OR¼1.06; 95% Cl: 1.00-1.11; p¼0.02) and male sex (c¼5.9; OR¼2.02;
95% Cl: 1.15-3.57; p¼0.015) as independent predictors of mortality in long term
outcome.
CONCLUSIONS In a consecutive series of elderly patients with NSTEACS, PCI is
associated with a low in hospital mortality rate and an improved event free survival at
10 years follow up.
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BACKGROUND Corrected QT (QTc) interval has been reported to prolong when the
myocardium is exposed to ischemia. However, little is known about the association
between prolonged QTc and coronary blood ﬂow to the infarct-related artery in the
setting of non-ST-elevation myocardial infarction (NSTEMI). We hypothesized that
prolonged QTc predicts impaired coronary blood ﬂow to the infarct-related artery in
patients with NSTEMI.
METHODS We performed a retrospective analysis of 481 consecutive patients with
NSTEMI who underwent coronary angiography within ﬁve days after presentation.
Patients with atrial ﬁbrillation, complete bundle branch block, paced rhythm,
electrolytes disturbance, history of coronary artery bypass grafting and those on
antiarrhythmic medication were excluded. Electrocardiography and coronary
angiography were reviewed by a blind fashion. The QT was measured manually
from the onset of QRS complex to the end of T wave, and QTc was calculated
using Bazett’s formula. QTc prolongation was deﬁned as QTc greater than 450ms
in men and 470ms in women. Baseline characteristics, electrocardiographic and
angiographic ﬁndings including Thrombolysis In Myocardial Infarction ﬂow grade
of the infarct-related artery were compared between patients with and without
prolonged QTc.
RESULTS Of the 340 patients included in the ﬁnal analysis, 130 patients (38.2%) had a
prolonged QTc interval. With respect to baseline characteristics, there was no sig-
niﬁcant difference between the two groups. There was no signiﬁcant difference in the
rate of TIMI grade 0/1 ﬂow (25.4% vs. 18.6%, p¼0.14) and prevalence of obstructive
coronary artery disease (76.9% vs. 75.2%, p¼0.72). Median QTc was 453 ms in patients
with TIMI 0/1 ﬂow and 449 ms in those with TIMI 2/3 ﬂow (p¼0.79). There was no
signiﬁcant difference in the rate of angiographic thrombus (p¼0.22), collateral cir-
culation to the infarct-related artery (p¼0.43) and in-hospital percutaneous or sur-
gical revascularization (p¼0.29) between patients with and without QTc
prolongation. The peak troponin I values were comparable between the two groups
(0.76 ng/mL vs. 0.62 ng/mL, p¼0.8).
CONCLUSION Prolonged QTc interval was observed in one-third of the NSTEMI pa-
tients in our cohort of patients. Contrary to our expectation, prolonged QTc did not
have a predictive value for impaired coronary ﬂow to the infarct-related artery in
patients with NSTEMI.ACUTE MYOCARDIAL INFARCTION
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BACKGROUND Primary PCI is the standard of care for those presenting with STEMI.
Trans-radial (TR) vascular access to perform PCI is superior to trans-femoral (TF)
access, mainly due to reduced bleeding, leading to overall mortality beneﬁt; patient
satisfaction remains very high. Limited skills, concerns with prolonged procedure
time, difﬁcult vascular anatomy, presence of cardiogenic shock (CS), previous CABG
and abnormal Allen’s test are limiting factors.
METHODS We are one of the tertiary cardiac centres in UK, and a default radial
centre. Since beginning of the 24/7 STEMI program, we have performed PPCI in 773
